Promapar
Brand names,
Promapar
Analogs
Promapar
Brand Names Mixture
Promapar
Chemical_Formula
C17H20N2S
Promapar
RX_link
No information avaliable
Promapar
fda sheet
Promapar
msds (material safety sheet)
Promapar
Synthesis Reference
No information avaliable
Promapar
Molecular Weight
284.42 g/mol
Promapar
Melting Point
< 25 oC
Promapar
H2O Solubility
14.2 mg/L
Promapar
State
Liquid
Promapar
LogP
4.893
Promapar
Dosage Forms
Tablet; Oral liquid; Injection
Promapar
Indication
Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
Promapar
Pharmacology
Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.
Promapar
Absorption
Absorption may be erratic and peak plasma concentrations show large interindividual differences.
Promapar
side effects and Toxicity
Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.
Promapar
Patient Information
No information avaliable
Promapar
Organisms Affected
Humans and other mammals